Atom | Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Due Dates: February 11, 2025 | June 11, 2025 | October 10, 2025 | January 11, 2026 | January 12, 2026 (final)

Funding Amounts: Budgets are not limited; UG3 phase up to 1 year, UH3 phase typically up to 4 years (max 6 years with justification); award size based on project needs.

Summary: Supports development and implementation of Clinical Coordinating Centers for investigator-initiated, multi-site clinical trials relevant to the NHLBI mission.

Key Information: CCC and companion DCC applications must be submitted together on the same due date for consideration.

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Sign in to see full grant listing